PerkinElmer to acquire Caliper Life Sciences

PerkinElmer, Inc. (Waltham, MA) has signed a definitive agreement to acquire molecular imaging and detection solutions provider Caliper Life Sciences, Inc. (Hopkinton, MA) for $10.50 per share, for a total net purchase price of approximately $600 million in cash.

Combining technology platforms will expand PerkinElmer's solutions and services offering, including molecular, cellular, animal and tissue imaging to enable translational medicine research; an added microfluidics platform for genomics and proteomics applications; sample preparation technologies for next-generation DNA sequencing; and platform technology additions to drive expansion into areas such as detection for environmental contaminants and food pathogens.

The acquisition's total purchase price represents a premium of 42% for Caliper Life Sciences shareholders, relative to the closing price of $7.39 on September 7, 2011, the last trading day prior to the announcement. The acquisition is expected to close in the fourth quarter of 2011, and be dilutive to PerkinElmer’s 2012 GAAP earnings per share by approximately $0.05 and accretive to PerkinElmer’s 2012 First Call consensus adjusted earnings per share by approximately $0.08.

The transaction is subject to customary closing conditions, including approval of Caliper Life Sciences stockholders.

Kevin Hrusovsky, Caliper Life Sciences' CEO, is anticipated to join the PerkinElmer senior leadership team following the close of the transaction.


Follow us on Twitter, 'like' us on Facebook, and join our group on LinkedIn

Follow OptoIQ on your iPhone; download the free app here.

Subscribe now to BioOptics World magazine; it's free!


Related Articles

Live-cell imaging with parallelized RESOLFT nanoscopy

Super-resolution microscopy of large fields in living cells possible with sCMOS

Super-resolution microscopy using a novel fluorescence microscope has enabled a team of researchers to perform real-time nanoscopic imaging of large fields of living cells for the first time.

Fluorescence imaging method using SWIR light detects cancer early

Rutgers University researchers have developed a fluorescence imaging method that has potential to detect cancer and other diseases earlier than before, potentially reducing the need for biopsies.

Optical coherence tomography skin screening system from MedLumics debuts

Optical coherence tomography (OCT) imaging device specialist MedLumics introduced its NITID skin imaging system at the 23rd Annual European Academy of Dermatology and Venereology Congress (EADV).
A light microscopy technique called lattice light-sheet microscopy imaged this single HeLa cell in metaphase

Light microscopy technique images molecules in 3D quickly, with minimal damage to cells

A light microscopy platform developed by Eric Betzig—one of three scientists sharing the 2014 Nobel Prize in Chemistry—and colleagues can collect high-resolution images rapidly with minimal damage ...

Neuro15 exhibitors meet exacting demands: Part 2

Increasingly, neuroscientists are working with researchers in disciplines such as chemistry and p...

Why be free?

A successful career contributed to keeping OpticalRayTracer—an optical design software program—fr...

LASER Munich 2015 is bio-bent

LASER World of Photonics 2015 included the European Conferences on Biomedical Optics among its si...

Most Popular Articles



Twitter- BioOptics World

Copyright © 2007-2014. PennWell Corporation, Tulsa, OK. All Rights Reserved.PRIVACY POLICY | TERMS AND CONDITIONS